Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor Gamma (PPAR-gamma) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes.
Zheng, W., Feng, X., Qiu, L., Pan, Z., Wang, R., Lin, S., Hou, D., Jin, L., Li, Y.(2013) Diabetologia 56: 401-411
- PubMed: 23178929 
- DOI: https://doi.org/10.1007/s00125-012-2777-9
- Primary Citation of Related Structures:  
4FGY - PubMed Abstract: 
Existing thiazolidinedione (TZD) drugs for diabetes have severe side effects. The aim of this study is to develop alternative peroxisome proliferator-activated receptor γ (PPARγ) ligands that retain the benefits in improving insulin resistance but with reduced side effects ...